FOLD icon

Amicus Therapeutics

257 hedge funds and large institutions have $2.74B invested in Amicus Therapeutics in 2021 Q1 according to their latest regulatory filings, with 52 funds opening new positions, 96 increasing their positions, 77 reducing their positions, and 63 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more call options, than puts

Call options by funds: $ | Put options by funds: $

less ownership

Funds ownership:

less funds holding

Funds holding:

17% less funds holding in top 10

Funds holding in top 10: 65 (-1)

17% less first-time investments, than exits

New positions opened: 52 | Existing positions closed: 63

58% less capital invested

Capital invested by funds: $6.44B → $2.74B (-$3.71B)

Holders
257
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
5
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$26.6M
Puts
$21.6M
Net Calls
Net Calls Change

Top Sellers

1 -$154M
2 -$31.2M
3 -$31.1M
4
Morgan Stanley
Morgan Stanley
New York
-$27.3M
5
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$26.3M
Name Holding Trade Value Shares
Change
Change in
Stake
76
$3.02M
77
$2.92M
78
$2.89M
79
$2.85M
80
$2.85M
81
$2.62M
82
$2.62M
83
$2.55M
84
$2.41M
85
$2.31M
86
$2.27M
87
$2.24M
88
$2.05M
89
$2.02M
90
$1.84M
91
$1.81M
92
$1.75M
93
$1.62M
94
$1.53M
95
$1.51M
96
$1.5M
97
$1.49M
98
$1.44M
99
$1.43M
100
$1.37M